These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 25461318

  • 21. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAFV600E and VEGFR-2 dual inhibitors.
    Wang Y, Wan S, Li Z, Fu Y, Wang G, Zhang J, Wu X.
    Eur J Med Chem; 2018 Jul 15; 155():210-228. PubMed ID: 29886324
    [Abstract] [Full Text] [Related]

  • 22. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities.
    El-Damasy AK, Lee JH, Seo SH, Cho NC, Pae AN, Keum G.
    Eur J Med Chem; 2016 Jun 10; 115():201-16. PubMed ID: 27017549
    [Abstract] [Full Text] [Related]

  • 23. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA, Abdel-Mohsen HT, El Kerdawy AM, Ragab FAF, Ali MM, Abu-Bakr SM, Girgis AS, El Diwani HI.
    Eur J Med Chem; 2017 Aug 18; 136():315-329. PubMed ID: 28505536
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W, Wang W, Xu S, Tang Q, Luo R, Wang M, Gong P, Zheng P.
    Bioorg Med Chem; 2016 Feb 15; 24(4):812-9. PubMed ID: 26810712
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors.
    Zhao MY, Yin Y, Yu XW, Sangani CB, Wang SF, Lu AM, Yang LF, Lv PC, Jiang MG, Zhu HL.
    Bioorg Med Chem; 2015 Jan 01; 23(1):46-54. PubMed ID: 25496804
    [Abstract] [Full Text] [Related]

  • 29. Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.
    Abdel-Maksoud MS, Ammar UM, Oh CH.
    Bioorg Med Chem; 2019 May 15; 27(10):2041-2051. PubMed ID: 30955995
    [Abstract] [Full Text] [Related]

  • 30. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.
    Chen KF, Tai WT, Huang JW, Hsu CY, Chen WL, Cheng AL, Chen PJ, Shiau CW.
    Eur J Med Chem; 2011 Jul 15; 46(7):2845-51. PubMed ID: 21531053
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W, Wang W, Xu S, Wang J, Tang Q, Wu C, Zhao Y, Zheng P.
    Bioorg Med Chem; 2016 Apr 15; 24(8):1749-56. PubMed ID: 26964675
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors.
    Chen X, Gong G, Chen X, Song R, Duan M, Qiao R, Jiao Y, Qi J, Chen Y, Zhu Y.
    Chem Pharm Bull (Tokyo); 2019 Apr 15; 67(10):1116-1122. PubMed ID: 31582631
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
    Wang M, Xu S, Lei H, Wang C, Xiao Z, Jia S, Zhi J, Zheng P, Zhu W.
    Bioorg Med Chem; 2017 Oct 15; 25(20):5754-5763. PubMed ID: 28927801
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatment.
    Jin F, Gao D, Zhang C, Liu F, Chu B, Chen Y, Chen YZ, Tan C, Jiang Y.
    Bioorg Med Chem; 2013 Feb 01; 21(3):824-31. PubMed ID: 23260578
    [Abstract] [Full Text] [Related]

  • 38. Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors.
    Abdel-Mohsen HT, Omar MA, El Kerdawy AM, Mahmoud AEE, Ali MM, El Diwani HI.
    Eur J Med Chem; 2019 Oct 01; 179():707-722. PubMed ID: 31284081
    [Abstract] [Full Text] [Related]

  • 39. Design, synthesis, and molecular docking study of 3H-imidazole[4,5-c]pyridine derivatives as CDK2 inhibitors.
    Wu YZ, Ying HZ, Xu L, Cheng G, Chen J, Hu YZ, Liu T, Dong XW.
    Arch Pharm (Weinheim); 2018 Jun 01; 351(6):e1700381. PubMed ID: 29708285
    [Abstract] [Full Text] [Related]

  • 40. [Synthesis and biological evaluation of sorafenib thiourea derivatives].
    Yang Z, Fang Z, Wang ZX, Wei P.
    Yao Xue Xue Bao; 2011 Sep 01; 46(9):1093-7. PubMed ID: 22121780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.